Singapore, Aug. 28 -- Global multi-omics leader Novogene is establishing its first Australian laboratory at Cabrini Health, bringing advanced genomic capabilities closer to Australian patients and researchers, reducing the wait for genomic test results that can inform cancer treatment decisions, and accelerating access to personalised treatment and precision diagnostic testing.

The joint laboratory will be strategically located within the clinical and cancer research precinct at Cabrini Malvern. Expected to open in 2027, it will become Australia's first genomics laboratory co-located within a private hospital.

Novogene's expansion into Australia marks a significant boost to Victoria's precision medicine capabilities, bringing industry-l...